Aclaris Therapeutics Stock Technical Analysis

ACRS Stock  USD 1.62  0.05  2.99%   
As of the 26th of March, Aclaris Therapeutics shows the Mean Deviation of 2.48, standard deviation of 3.32, and Risk Adjusted Performance of (0.22). Aclaris Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aclaris Therapeutics standard deviation and value at risk to decide if Aclaris Therapeutics is priced correctly, providing market reflects its regular price of 1.62 per share. Please also double-check Aclaris Therapeutics jensen alpha, which is currently at (0.91) to validate the company can sustain itself at a future point.

Aclaris Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aclaris, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Aclaris
  
Aclaris Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Aclaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aclaris Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aclaris Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Aclaris Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aclaris Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Aclaris Therapeutics Trend Analysis

Use this graph to draw trend lines for Aclaris Therapeutics. You can use it to identify possible trend reversals for Aclaris Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Aclaris Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Aclaris Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Aclaris Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.02  , which may suggest that Aclaris Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 14.84, which is the sum of squared deviations for the predicted Aclaris Therapeutics price change compared to its average price change.

About Aclaris Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aclaris Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aclaris Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aclaris Therapeutics price pattern first instead of the macroeconomic environment surrounding Aclaris Therapeutics. By analyzing Aclaris Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aclaris Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aclaris Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Aclaris Therapeutics March 26, 2025 Technical Indicators

Most technical analysis of Aclaris help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aclaris from various momentum indicators to cycle indicators. When you analyze Aclaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Aclaris Therapeutics March 26, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Aclaris stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.